1 / 11

AIDS EPIDEMIC IN COTE DIVOIRE

AIDS EPIDEMIC IN COTE DIVOIRE. TCHOMIAN Clement ADJE Technical Advisor, for care and support EGPAF. Surface area 322 400 km2 / population 20m. ABIDJAN. BASILIC ND DE LA PAIX. SITUATION. Prevalence: UNAIDS /WHO, 3.4% in 2009. 450 000 people infected by HIV in Côte d’Ivoire

lei
Download Presentation

AIDS EPIDEMIC IN COTE DIVOIRE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. AIDS EPIDEMIC IN COTE DIVOIRE TCHOMIAN Clement ADJE Technical Advisor, for care and support EGPAF

  2. Surface area 322 400 km2 / population 20m

  3. ABIDJAN

  4. BASILIC ND DE LA PAIX

  5. SITUATION • Prevalence: UNAIDS /WHO, 3.4% in 2009. • 450 000 people infected by HIV in Côte d’Ivoire • 220 000 female • Majority of infected patients 15 years old and 63 000 children under 14 years old. • Patients treated HAART • 82 7212 in 2010 • 89 410 en 2011 • 36 Death Relay to HIV

  6. SITUATION • SITUATION: 90% site integrated HIV care in the routine service • Laboratories • VL laboratories available • Genotype test resistance 2 LABs available • CD4 available in 150 sites • SITES • HIV Testing all the sites ( 400 sites for care and treatment and 600 sites for PMTCT

  7. CHALENGES • Integration of HIV management in all sites • Eradication of HIV in pediatric care service • HIV National Program financing by PEPFAR CDC and other • HIV Patients often expose to drug starvation • Lost of follow up about 35% of patients initiated HIV therapy “BIG CHALENGES”

  8. How do we plan if we are totally dependent on international financing for our national HIV program? Loss to Follow-up Drug Availability? Lack of funds? VL in routine genotypical test

  9. Which Gold standard of care do we want for African HIV patients? At the end of the day the difference is clear

  10. Despite all these challenges life continues

  11. European AIDS Clinical Society THANK YOU

More Related